• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压前期与高血压及对一般人群估算肾小球滤过率下降预测:队列研究的荟萃分析。

Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies.

机构信息

Division of Nephrology, Second University of Naples, Naples, Italy.

Division of Nephrology, Second University of Naples, Naples, Italy.

出版信息

Am J Kidney Dis. 2016 Jan;67(1):89-97. doi: 10.1053/j.ajkd.2015.08.027. Epub 2015 Oct 23.

DOI:10.1053/j.ajkd.2015.08.027
PMID:26475392
Abstract

BACKGROUND

Whether blood pressure (BP) plays an independent predictive role in the onset of decreased glomerular filtration rate (GFR) remains ill-defined because existing meta-analyses have incorporated data from studies that included individuals with low GFRs at baseline. This question is critical to optimize chronic kidney disease prevention in the general population.

STUDY DESIGN

Systematic review and meta-analysis of longitudinal cohort studies.

SETTING & POPULATION: Adults from general population.

SELECTION CRITERIA FOR STUDIES

We identified in PubMed, EMBASE, and the Cochrane Library database all cohort studies evaluating the role of BP in the incidence of decreased estimated GFR (eGFR; defined as eGFR<60 mL/min/1.73 m2) in individuals without decreased kidney function at baseline.

PREDICTORS

Hypertension (BP>140/90 mmHg), prehypertension (systolic BP of 120-139 and/or diastolic BP of 80-89 mmHg), and BP as a continuous variable.

OUTCOMES

Risk for decreased eGFR reported as relative risk (RR) and 95% CI. Heterogeneity (I2) was also evaluated.

RESULTS

Data from 16 cohorts (315,321 participants) were analyzed. All studies had a Newcastle-Ottawa score in the range of 6 to 8, denoting high quality. During a mean follow-up of 6.5 years, decreased eGFR occurred in 6.6% of participants. The presence of prehypertension and hypertension increased renal risk (RRs of 1.19 [95% CI, 1.07-1.33; I2=23.8%] and 1.76 [95% CI, 1.58-1.97; I2=37.7%], respectively). Similarly, we found that every 10-mm Hg increase in systolic and diastolic BPs associated with higher risk for decreased eGFR (RRs of 1.08 [95% CI, 1.04-1.11; I2=60.0%] and 1.12 [95% CI, 1.04-1.20; I2=51.4%], respectively). Metaregression analysis showed greater risk with older age (P=0.03), whereas other covariates were not significant.

LIMITATIONS

No individual patient-level data.

CONCLUSIONS

Prehypertension and hypertension, as BP levels, are independent predictors of decreased GFR in the general population, with the effect being more pronounced in the elderly. These findings are important for improving risk stratification in the general population.

摘要

背景

血压(BP)是否在肾小球滤过率(GFR)下降的发生中起独立的预测作用仍不清楚,因为现有的荟萃分析纳入了基线时 GFR 较低的研究数据。这个问题对于优化一般人群的慢性肾脏病预防至关重要。

研究设计

系统评价和纵向队列研究的荟萃分析。

研究场所和人群

来自一般人群的成年人。

研究选择标准

我们在 PubMed、EMBASE 和 Cochrane 图书馆数据库中检索了所有评估血压在基线时肾功能正常的个体中估计肾小球滤过率(eGFR;定义为 eGFR<60mL/min/1.73m2)下降发生率中的作用的队列研究。

预测因素

高血压(BP>140/90mmHg)、前期高血压(收缩压 120-139mmHg 和/或舒张压 80-89mmHg)和 BP 作为连续变量。

结局

报告为相对风险(RR)和 95%置信区间的 eGFR 下降风险。还评估了异质性(I2)。

结果

分析了 16 项队列研究(315321 名参与者)的数据。所有研究的 Newcastle-Ottawa 评分均在 6 至 8 分之间,表明质量较高。在平均 6.5 年的随访期间,6.6%的参与者出现 eGFR 下降。前期高血压和高血压的存在增加了肾脏风险(RRs 分别为 1.19(95%CI,1.07-1.33;I2=23.8%)和 1.76(95%CI,1.58-1.97;I2=37.7%))。同样,我们发现收缩压和舒张压每升高 10mmHg,eGFR 下降的风险就会增加(RRs 分别为 1.08(95%CI,1.04-1.11;I2=60.0%)和 1.12(95%CI,1.04-1.20;I2=51.4%))。Meta 回归分析表明,年龄较大时风险更高(P=0.03),而其他协变量则不显著。

局限性

没有个体患者水平的数据。

结论

前期高血压和高血压作为血压水平,是一般人群 GFR 下降的独立预测因素,在老年人中作用更为明显。这些发现对于改善一般人群的风险分层很重要。

相似文献

1
Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies.高血压前期与高血压及对一般人群估算肾小球滤过率下降预测:队列研究的荟萃分析。
Am J Kidney Dis. 2016 Jan;67(1):89-97. doi: 10.1053/j.ajkd.2015.08.027. Epub 2015 Oct 23.
2
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
3
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
4
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Renal denervation for resistant hypertension.肾去神经术治疗顽固性高血压。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD011499. doi: 10.1002/14651858.CD011499.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
The dilemma of chronic kidney disease and end-stage kidney disease following pre-eclampsia: a literature review and meta-analysis.子痫前期后慢性肾脏病和终末期肾病的困境:一项文献综述和荟萃分析
Int Urol Nephrol. 2025 Jun 7. doi: 10.1007/s11255-025-04591-2.
2
The effect of daily physical activity on bidirectional transitions of elevated blood pressure status: the first longitudinal evidence from the CHARLS.日常身体活动对血压升高状态双向转变的影响:来自中国健康与养老追踪调查(CHARLS)的首个纵向证据。
BMC Public Health. 2025 Jun 5;25(1):2104. doi: 10.1186/s12889-025-23296-w.
3
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.
接受培戈洛酶治疗的痛风控制不佳的肾移植受者的生活质量改善及临床评估:4期PROTECT临床试验结果
Front Immunol. 2025 Mar 13;16:1516146. doi: 10.3389/fimmu.2025.1516146. eCollection 2025.
4
The Effectiveness of Telehealth Intervention on Chronic Kidney Disease Management in Adults: A Systematic Review.远程医疗干预对成人慢性肾脏病管理的有效性:一项系统综述。
Mayo Clin Proc Digit Health. 2024 Nov 16;3(1):100181. doi: 10.1016/j.mcpdig.2024.11.002. eCollection 2025 Mar.
5
Association of Kidney Function With 10-Year Risk of Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Its Risk Factors Among Women With Type 2 Diabetes Mellitus.2型糖尿病女性患者的肾功能与动脉粥样硬化性心血管疾病、心血管疾病及其危险因素的10年风险的关联
Int J Womens Health. 2025 Feb 18;17:449-457. doi: 10.2147/IJWH.S485470. eCollection 2025.
6
Circadian blood pressure variability and associated factors among chronic kidney disease patients at Nekemte Town public Hospitals, West Oromia, Ethiopia: a comparative cross-sectional study.埃塞俄比亚西奥罗米亚州内克姆特镇公立医院慢性肾脏病患者的昼夜血压变异性及相关因素:一项对比性横断面研究。
BMJ Open. 2024 Aug 28;14(8):e083014. doi: 10.1136/bmjopen-2023-083014.
7
The effect of hyperuricemia and its interaction with hypertension towards chronic kidney disease in patients with type 2 diabetes: evidence from a cross- sectional study in Eastern China.高尿酸血症及其与高血压对中国东部 2 型糖尿病患者慢性肾脏病的影响:一项横断面研究的证据。
Front Endocrinol (Lausanne). 2024 Jul 29;15:1415459. doi: 10.3389/fendo.2024.1415459. eCollection 2024.
8
Urotensin II system in chronic kidney disease.慢性肾脏病中的尾加压素II系统
Curr Res Physiol. 2024 May 7;7:100126. doi: 10.1016/j.crphys.2024.100126. eCollection 2024.
9
Role of Nutrients in Pediatric Non-Dialysis Chronic Kidney Disease: From Pathogenesis to Correct Supplementation.营养物质在儿童非透析慢性肾脏病中的作用:从发病机制到正确补充
Biomedicines. 2024 Apr 19;12(4):911. doi: 10.3390/biomedicines12040911.
10
Kidney dysfunction predicts 90 days mortality after stroke thrombectomy independent of cardiovascular risk factors and chronic kidney disease.肾功能障碍可预测卒中介入取栓后 90 天的死亡率,与心血管危险因素和慢性肾脏病无关。
Eur Stroke J. 2024 Jun;9(2):424-431. doi: 10.1177/23969873231224200. Epub 2024 Jan 9.